Inhibitors of cell cycle checkpoint target Wee1 kinase – a patent review (2003–2022)
Author:
Affiliation:
1. School of Science, China Pharmaceutical University, Nanjing, P.R. China
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543776.2022.2166827
Reference101 articles.
1. Control of the yeast cell cycle by the Cdc28 protein kinase
2. Multiple levels of cyclin specificity in cell-cycle control
3. Cell cycle proteins as promising targets in cancer therapy
4. Conserved functions of the pRB and E2F families
5. Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1;Cancer Cell International;2024-09-13
2. Advanced Design, Synthesis, and Evaluation of Highly Selective Wee1 Inhibitors: Enhancing Pharmacokinetics and Antitumor Efficacy;Journal of Medicinal Chemistry;2024-06-07
3. The power and the promise of synthetic lethality for clinical application in cancer treatment;Biomedicine & Pharmacotherapy;2024-03
4. Antifungal Activity and Action Mechanisms of 2,4-Di-tert-butylphenol against Ustilaginoidea virens;Journal of Agricultural and Food Chemistry;2023-11-08
5. Inhibitory function of CDK12i combined with WEE1i on castration-resistant prostate cancer cells in vitro and in vivo;Oncologie;2023-08-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3